Moderate to severe OSA was associated with increased risk for severe and critical COVID-19, particularly in those with severe intermittent hypoxia.

A new study published in the Journal of Psychiatric Research has found that many individuals who were hospitalized with COVID-19 continue to show signs of impaired attention up to three months after ...

Patients fear the clinic’s closure will end their access to the latest research, clinical trials for new treatments, and ...

Long COVID destroys teenage lungs in ways doctors never saw - silent damage persists months after mild infections in developing adolescents.

University of Virginia researchers uncover immune system changes linked to lung damage in Long COVID patients, offering hope for personalized treatments to address lingering respiratory complications.

The findings hold promise for developing targeted treatments for the lung complications of Long COVID.

Credit: NIAID In this study, the researchers discovered that severe lung infections, such as COVID-19 can severely damage structures called peroxisomes in certain immune cells known as macrophages.

Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.

A COVID-19 study done at the University of Virginia (UVA) has the potential to create new treatment approaches for chronic lung problems.

Post-COVID pulmonary fibrosis, which involves scarring of the lungs that can worsen over time and may require a lung transplant, affects some patients after infection, according to pulmonologists.